Literature DB >> 12614977

Leptin treatment ameliorates anxiety in ob/ob obese mice.

Akihiro Asakawa1, Akio Inui, Toshio Inui, Goro Katsuura, Masayuki A Fujino, Masato Kasuga.   

Abstract

We investigated whether or not administered leptin influences anxiety-like behavior in ob/ob mice. Repeated intraperitoneal administrations of leptin were continued for 5 days. Anxiety was assessed in the standard elevated plus maze. Body weight was measured daily. Repeated administrations of leptin significantly increased the percentage of the total number of entries in the open arms and the number of total entries. The body weight was significantly reduced by 13.2% after treatment. Leptin treatment ameliorated not only obesity but also anxiety in ob/ob mice. Our results indicate that the treatment of obesity may lead to the solution of psychological problems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614977     DOI: 10.1016/s1056-8727(02)00185-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  24 in total

Review 1.  Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa.

Authors:  A Torsello; F Brambilla; L Tamiazzo; I Bulgarelli; D Rapetti; E Bresciani; V Locatelli
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

Review 2.  The impact of leptin on perinatal development and psychopathology.

Authors:  Jeanette C Valleau; Elinor L Sullivan
Journal:  J Chem Neuroanat       Date:  2014-05-23       Impact factor: 3.052

3.  Leptin-deficient mice retain normal appetitive spatial learning yet exhibit marked increases in anxiety-related behaviours.

Authors:  Beate C Finger; Timothy G Dinan; John F Cryan
Journal:  Psychopharmacology (Berl)       Date:  2010-04-27       Impact factor: 4.530

Review 4.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

5.  The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.

Authors:  Lin Li
Journal:  CNS Drugs       Date:  2017-07       Impact factor: 5.749

Review 6.  Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications.

Authors:  Lawrence P Reagan
Journal:  Exp Neurol       Date:  2011-02-12       Impact factor: 5.330

7.  Neurobehavioral deficits in db/db diabetic mice.

Authors:  Ajaykumar N Sharma; Khalid M Elased; Teresa L Garrett; James B Lucot
Journal:  Physiol Behav       Date:  2010-07-14

8.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.

Authors:  Alexis M Stranahan; Kim Lee; Bronwen Martin; Stuart Maudsley; Erin Golden; Roy G Cutler; Mark P Mattson
Journal:  Hippocampus       Date:  2009-10       Impact factor: 3.899

9.  Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine.

Authors:  Jing Liu; Jacob C Garza; Jamaur Bronner; Chung Sub Kim; Wei Zhang; Xin-Yun Lu
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

10.  Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice.

Authors:  Matthew J Muelbl; Natalie N Nawarawong; Patrick T Clancy; Catherine E Nettesheim; Yi Wei Lim; Christopher M Olsen
Journal:  Psychopharmacology (Berl)       Date:  2016-06-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.